In that connection, preclinical studies revealed that a humanized form of a murine Cd74 antibody is able to effectively inhibit tumor growth and yielded marked survival improvements in severe combined immunodeficiency mouse xenograft models of non-Hodgkin lymphomas and multiple myeloma, respectively [36]. Here, CD74 is linked to neoplasm.